About Ankyrin repeat and SOCS box protein 16
Ankyrin repeat and SOCS box protein 16 (ASB16) is a protein
from Homo sapiens identified by UniProt accession
Q96NS5, 453 residues long.
MolForge cross-references it against 0 known binders and
75 disease associations.
Target properties
| Protein name | Ankyrin repeat and SOCS box protein 16 |
| UniProt accession | Q96NS5 |
| Gene | ASB16 |
| Organism | Homo sapiens |
| Length | 453 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (75)
Diseases linked to this target (Open Targets).
- HbA1c measurement · score 0.25
- hematocrit · score 0.21
- mean platelet volume · score 0.21
- body mass index · score 0.20
- calcium measurement · score 0.19
- body weight · score 0.19
- clear cell renal carcinoma · score 0.18
- bipolar disorder · score 0.18
- body fat distribution · score 0.18
- red blood cell density measurement · score 0.18
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96NS5-F1 | alphafold | PREDICTED | 88.98 | — |
Amino-acid sequence (453 residues)
MARETFPFTS SMLRSLRLQQ EWLEWEDRRR AAAQQCRSRR CPSSPRARLT RPHRSCRDPA VHQALFSGNL QQVQALFQDE EAANMIVETV SNQLAWSAEQ GFWVLTPKTK QTAPLAIATA RGYTDCARHL IRQGAELDAR VGGRAALHEA CARAQFDCVR LLLTFGAKAN VLTEEGTTPL HLCTIPESLQ CAKLLLEAGA TVNLAAGESQ ETPLHVAAAR GLEQHVALYL EHGADVGLRT SQGETALNTA CAGAEGPGSC RRHQAAARRL LEAGADARAA GRKRHTPLHN ACANGCGGLA ELLLRYGARA EVPNGAGHTP MDCALQAVQD SPNWEPEVLF AALLDYGAQP VRPEMLKHCA NFPRALEVLL NAYPCVPSCE TWVEAVLPEL WKEHEAFYSS ALCMVNQPRQ LQHLARLAVR ARLGSRCRQG ATRLPLPPLL RDYLLLRVEG CIQ
Explore Ankyrin repeat and SOCS box protein 16 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets